# Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older

> **NCT05541289** · — · NO_LONGER_AVAILABLE · sponsor: **Ocugen**

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** BBV152

## Key facts

- **NCT ID:** NCT05541289
- **Lead sponsor:** Ocugen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05541289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05541289, "Expanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and Older". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05541289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*